Novartis is replacing the CEO of Alcon unit as part of a broad restructuring caused by falling sales. The company reported that Mike Ball, will replace Jeff George at the helm of Alcon on Feb. 1, 2016.
George is leaving the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
80 CHF | -0.42% | -2.77% | +21.88% |
29/05 | Switzerland's Alcon Launches Middle East Headquarters in Saudi Arabia | MT |
22/05 | UBS Lifts Alcon PT, Keeps Buy Recommendation | MT |
Novartis is replacing the CEO of Alcon unit as part of a broad restructuring caused by falling sales. The company reported that Mike Ball, will replace Jeff George at the helm of Alcon on Feb. 1, 2016.
George is leaving the company.
1st Jan change | Capi. | |
---|---|---|
+21.88% | 43.96B | |
+13.00% | 101B | |
-1.41% | 18.78B | |
-20.90% | 2.22B | |
+25.39% | 2.11B | |
+20.18% | 1.13B | |
-39.75% | 716M | |
-10.29% | 645M | |
-42.87% | 632M | |
+52.97% | 606M |